Haleon plc Share Price

Equities

HLN

GB00BMX86B70

Pharmaceuticals

Market Closed - London S.E. 09:05:01 26/04/2024 pm IST 5-day change 1st Jan Change
334.4 GBX +0.87% Intraday chart for Haleon plc +2.64% +3.96%

Financials

Sales 2024 * 11.45B 14.32B 1,192B Sales 2025 * 11.93B 14.93B 1,242B Capitalization 30.54B 38.21B 3,180B
Net income 2024 * 1.47B 1.84B 153B Net income 2025 * 1.69B 2.12B 176B EV / Sales 2024 * 3.35 x
Net Debt 2024 * 7.85B 9.82B 817B Net Debt 2025 * 7.11B 8.89B 740B EV / Sales 2025 * 3.15 x
P/E ratio 2024 *
20.7 x
P/E ratio 2025 *
18.1 x
Employees 25,408
Yield 2024 *
1.88%
Yield 2025 *
2.15%
Free-Float 77.45%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.87%
1 week+2.64%
Current month+0.39%
1 month+0.39%
3 months+5.22%
6 months+4.16%
Current year+3.96%
More quotes
1 week
328.30
Extreme 328.3
336.00
1 month
319.20
Extreme 319.2
336.00
Current year
308.37
Extreme 308.3696
342.15
1 year
306.80
Extreme 306.8
353.10
3 years
241.17
Extreme 241.1735
357.65
5 years
241.17
Extreme 241.1735
357.65
10 years
241.17
Extreme 241.1735
357.65
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 22/21/22
Director of Finance/CFO 52 01/21/01
Chief Tech/Sci/R&D Officer - 16/21/16
Members of the board TitleAgeSince
Director/Board Member - 18/22/18
Director/Board Member 63 18/22/18
Director/Board Member 57 18/22/18
More insiders
Date Price Change Volume
26/24/26 334.4 +0.87% 23,216,110
25/24/25 331.5 +0.58% 22,088,610
24/24/24 329.6 -0.96% 19,132,230
23/24/23 332.8 +0.57% 35,979,960
22/24/22 330.9 +1.57% 16,067,920

Delayed Quote London S.E., April 26, 2024 at 09:05 pm IST

More quotes
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.344 GBP
Average target price
3.594 GBP
Spread / Average Target
+7.47%
Consensus